160 related articles for article (PubMed ID: 37917812)
1. Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case report.
Shang P; Lou C; Yin L; Tao C; Dong Y; Yang G; Yuan Z
J Int Med Res; 2023 Nov; 51(11):3000605231204502. PubMed ID: 37917812
[TBL] [Abstract][Full Text] [Related]
2. Real-world association of HER2/
Stein SM; Snider J; Ali SM; Miksad RA; Alexander BM; Castellanos E; Schrock AB; Madison R; Swaminathan A; Venstrom JM; McCusker M
Future Oncol; 2021 Nov; 17(31):4101-4114. PubMed ID: 34463133
[TBL] [Abstract][Full Text] [Related]
3. Primary carcinoma of renal calyx.
Williams PA; Mai KT
Pathol Res Pract; 2013 Oct; 209(10):654-61. PubMed ID: 23999038
[TBL] [Abstract][Full Text] [Related]
4. Ado-trastuzumab emtansine in the treatment of lung adenocarcinoma with ERBB2 mutation: a case report and literature review.
Wang H; He Y; Zhao W; Tong Z
Anticancer Drugs; 2022 Sep; 33(8):773-777. PubMed ID: 35946510
[TBL] [Abstract][Full Text] [Related]
5. Human epidermal growth factor receptor 2 expression in urothelial carcinoma of the renal pelvis: correlation with clinicopathologic parameters.
Ehsani L; Osunkoya AO
Int J Clin Exp Pathol; 2014; 7(5):2544-50. PubMed ID: 24966967
[TBL] [Abstract][Full Text] [Related]
6. Targeting ERBB2 mutations in solid tumors: biological and clinical implications.
Cousin S; Khalifa E; Crombe A; Laizet Y; Lucchesi C; Toulmonde M; Le Moulec S; Auzanneau C; Soubeyran I; Italiano A
J Hematol Oncol; 2018 Jun; 11(1):86. PubMed ID: 29941010
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous resection of metastatic renal cell carcinoma.
Toussi A; Agarwal D; Leibovich B; Potretzke A
Int Braz J Urol; 2019; 45(3):640. PubMed ID: 30620159
[TBL] [Abstract][Full Text] [Related]
8. Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With
Ganti AK; Rothe M; Mangat PK; Garrett-Mayer E; Dib EG; Duvivier HL; Ahn ER; Behl D; Borghaei H; Balmanoukian AS; Gaba A; Li R; Osei-Boateng K; Thota R; Grantham GN; Gregory A; Halabi S; Schilsky RL
JCO Precis Oncol; 2023 Jun; 7():e2300041. PubMed ID: 37315265
[TBL] [Abstract][Full Text] [Related]
9. HER2 Status in Molecular Subtypes of Urothelial Carcinoma of the Renal Pelvis and Ureter.
Yorozu T; Sato S; Kimura T; Iwatani K; Onuma H; Yanagisawa T; Miki J; Egawa S; Ikegami M; Takahashi H
Clin Genitourin Cancer; 2020 Aug; 18(4):e443-e449. PubMed ID: 31983622
[TBL] [Abstract][Full Text] [Related]
10. Case report of renal pelvis squamous cell carcinoma with tumor embolus in autosomal dominant polycystic kidney disease.
Xie J; Zhang XB; Wang WZ; Li HZ
Medicine (Baltimore); 2016 Aug; 95(33):e4597. PubMed ID: 27537592
[TBL] [Abstract][Full Text] [Related]
11. Oral metastasis from primary transitional cell carcinoma of the renal pelvis: report of a case.
Zhang Y; Gu ZY; Tian Z; Yang C; Cai XY
Int J Oral Maxillofac Surg; 2010 Jul; 39(7):737-9. PubMed ID: 20236801
[TBL] [Abstract][Full Text] [Related]
12. Next-Generation Sequencing and In Silico Analysis Facilitate Prolonged Response to Pazopanib in a Patient With Metastatic Urothelial Carcinoma of the Renal Pelvis.
Hahn AW; Giri S; Patel D; Sluder H; Vanderwalde A; Martin MG
J Natl Compr Canc Netw; 2015 Oct; 13(10):1181-5. PubMed ID: 26483058
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Effective Treatment With Pyrotinib and Capecitabine in a Heavily Pretreated Locally Advanced Breast Cancer Harboring Both HER2 Overexpression and Mutant.
Gao Z; Xu J; Wang Y; Wu J; Sun T
Front Oncol; 2021; 11():715554. PubMed ID: 34722261
[TBL] [Abstract][Full Text] [Related]
14. [Description of a case of squamous cell carcinoma of the renal pelvis].
Vella R; Manini C; Piccoli F; Revelli G
Minerva Urol Nefrol; 1995 Mar; 47(1):43-7. PubMed ID: 7570260
[TBL] [Abstract][Full Text] [Related]
15. Paraganglioma of the renal pelvis: a case report and review of literature.
Yi C; Han L; Yang R; Yu J
Tumori; 2017 Nov; 103(Suppl. 1):e47-e49. PubMed ID: 28799639
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma in a duplicated renal pelvis.
Ogawa M; Morikawa T; Toyoshima T; Fukayama M
Int J Clin Exp Pathol; 2014; 7(11):7957-61. PubMed ID: 25550838
[TBL] [Abstract][Full Text] [Related]
17. Hepatoid adenocarcinoma of the renal pelvis in a 59-year-old male with nephrolithiasis: Case report and review of the literature.
Huang J; Zhu R; Wu R; Li R; Yao N; Deng S
Curr Probl Cancer; 2019 Oct; 43(5):471-476. PubMed ID: 30683324
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of pyrotinib for bone marrow metastasis induced pancytopenia in a patient with non-small-cell lung cancer and ERBB2 mutation.
Wu Y; Ni J; Chang X; Zhang X; Zhang L
Thorac Cancer; 2020 Jul; 11(7):2051-2055. PubMed ID: 32458584
[TBL] [Abstract][Full Text] [Related]
19. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer.
Hergueta-Redondo M; Sarrio D; Molina-Crespo Á; Vicario R; Bernadó-Morales C; Martínez L; Rojo-Sebastián A; Serra-Musach J; Mota A; Martínez-Ramírez Á; Castilla MÁ; González-Martin A; Pernas S; Cano A; Cortes J; Nuciforo PG; Peg V; Palacios J; Pujana MÁ; Arribas J; Moreno-Bueno G
Oncotarget; 2016 Aug; 7(35):56295-56308. PubMed ID: 27462779
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Features, Tumor Mutational Burden, and Tumour-Infiltrating Lymphocyte Interplay in
Uchida S; Kojima T; Sugino T
Pathol Oncol Res; 2021; 27():633243. PubMed ID: 34257600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
